Development, implementation and evaluation of an electronic medical record prompt for bone density testing

Health Informatics Journal

Volumn 15, Issue 4, 2009, Pages 296-304

  Rolnick, Sharon J ^a   Jackson, Jody M ^a   Amundson, Jerry H ^a  

^a HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

Author keywords

Attitude of health personnel; Bone density; Clinical practice; Decision support systems; Medical record systems; Reminder systems

Indexed keywords

ANTIINFLAMMATORY AGENT; PREDNISONE;

ALGORITHM; ARTICLE; BONE DENSITY; DECISION SUPPORT SYSTEM; DRUG EFFECT; EVALUATION; HEALTH PERSONNEL ATTITUDE; HUMAN; MEDICAL RECORD; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; REMINDER SYSTEM; RHEUMATOLOGY; UTILIZATION REVIEW;

ABSORPTIOMETRY, PHOTON; ALGORITHMS; ANTI-INFLAMMATORY AGENTS; ATTITUDE OF HEALTH PERSONNEL; BONE DENSITY; DECISION SUPPORT SYSTEMS, CLINICAL; ELECTRONIC HEALTH RECORDS; HUMANS; OSTEOPOROSIS; PREDNISONE; REMINDER SYSTEMS; RHEUMATOLOGY;

EID: 75149120593     PISSN: 14604582     EISSN: 17412811     Source Type: Journal    
DOI: 10.1177/1460458209345900     Document Type: Article

References (42)

1. Garg A.X., Adhikari N.K., McDonald H., et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. Journal of the American Medical Association 2005 ; 293 (10). 1223-1238.
2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. Journal of the American Medical Association 1995 ; 273 (3). 199-208.
3. Adams M.R., Kaplan J.R., Manuck S.B., et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 1990 ; 10 (6). 1051-1057.
4. Adams M.R., Register T.C., Golden D.L., Wagner J.D., Williams J.K. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arteriosclerosis, Thrombosis & Vascular Biology 1997 ; 17 (1). 217-221.
5. Barrett-Connor E., Wehren L.E., Siris E.S., et al. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study. Menopause 2003 ; 10 (5). 412-419.
6. Binder E.F., Williams D.B., Schechtman K.B., Jeffe D.B., Kohrt W.M. Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial. Annals of Internal Medicine 2001 ; 134 (9 Part 1). 754-760.
7. Cauley J.A., Robbins J., Chen Z., et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Womens Health Initiative randomized trial. Journal of the American Medical Association 2003 ; 290 (13). 1729-1738.
8. Greenspan S.L., Resnick N.M., Parker R.A. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial. Journal of the American Medical Association 2003 ; 289 (19). 2525-2533.
9. Kamel H.K., Perry H.M. 3rd, Morley J.E. Hormone replacement therapy and fractures in older adults. Journal of the American Geriatric Society 2001 ; 49 (2). 179-187.
10. Kawas C., Resnick S., Morrison A., et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimers disease: the Baltimore Longitudinal Study of Aging. Neurology 1997 ; 48 (6). 1517-1521.
11. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause 1994 ; 1 (3). 125-130.
12. Paganini-Hill A., Henderson V.W. Estrogen replacement therapy and risk of Alzheimer disease. Archives of Internal Medicine 1996 ; 156 (19). 2213-2217. (Pubitemid 26361914)
13. Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses health study. New England Journal of Medicine 1991 ; 325 (11). 756-762.
14. Torgerson D.J., Bell-Syer S.E. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. Journal of the American Medical Association 2001 ; 285 (22). 2891-2897.
15. Williams J.K., Honore E.K., Washburn S.A., Clarkson T.B. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. Journal of the American College of Cardiology 1994 ; 24 (7). 1757-1761.
16. Davidson M.H., Maki K.C., Marx P., et al. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Archives of Internal Medicine 2000 ; 160 (21). 3315-3325.
17. Jneid H., Thacker H.L. Coronary artery disease in women: different, often undertreated. Cleveland Clinic Journal of Medicine 2001 ; 68 (5). 441-448.
18. Grodstein F., Newcomb P.A., Stampfer M.J. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. American Journal of Medicine 1999 ; 106 (5). 574-582. (Pubitemid 29231110)
19. LeBlanc E.S., Janowsky J., Chan B.K., Nelson H.D. Hormone replacement therapy and cognition: systematic review and meta-analysis. Journal of the American Medical Association 2001 ; 285 (11). 1489-1499.
20. Shaywitz S.E., Shaywitz B.A., Pugh K.R., et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. Journal of the American Medical Association 1999 ; 281 (13). 1197-1202.
21. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Annals of Internal Medicine 2005 ; 142 (10). 855-860.
22. Barrett-Connor E., Grady D., Stefanick M.L. The rise and fall of menopausal hormone therapy. Annual Review of Public Health 2005 ; 26 ; 115-140.
23. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Womens Health Initiative randomized controlled trial. Journal of the American Medical Association 2002 ; 288 (3). 321-333.
24. Stephenson J. FDA orders estrogen safety warnings: Agency offers guidance for HRT use. Journal of the American Medical Association 2003 ; 289 (5). 537-538.
25. Rolnick S.J., Kopher R.A., DeFor T.A., Kelley M.E. Hormone use and patient concerns after the findings of the Womens Health Initiative. Menopause 2005 ; 12 (4). 399-404.
26. Rolnick S.J., Jackson J., Kopher R., Defor T.A. Provider management of menopause after the findings of the Womens Health Initiative. Menopause 2007 ; 14 (3 Pt 1). 441-449.
27. Saleem J.J., Patterson E.S., Militello L., Render M.L., Orshansky G., Asch S.M. Exploring barriers and facilitators to the use of computerized clinical reminders. Journal of the American Medical Informatics Association 2005 ; 12 (4). 438-447. (Pubitemid 40922905)
28. Balas E.A., Weingarten S., Garb C.T., Blumenthal D., Boren S.A., Brown G.D. Improving preventive care by prompting physicians. Archives of Internal Medicine 2000 ; 160 (3). 301-308.
29. Dexheimer J.W., Sanders D.L., Rosenbloom S.T., Aronsky D. Prompting clinicians: a systematic review of preventive care reminders. AMIA Annual Symposium Proceedings 2005: 938.
30. Dexheimer J.W., Talbot T.R., Sanders D.L., Rosenbloom S.T., Aronsky D. Prompting clinicians about preventive care measures: A systematic review of randomized controlled trials. Journal of the American Medical Informatics Association 2008 ; 15 (3). 311-320.
31. Fiks A.G., Grundmeier R.W., Biggs L.M., Localio A.R., Alessandrini E.A. Impact of clinical alerts within an electronic health record on routine childhood immunization in an urban pediatric population. Pediatrics 2007 ; 120 (4). 707-714.
32. Garr D.R., Ornstein S.M., Jenkins R.G., Zemp L.D. The effect of routine use of computer-generated preventive reminders in a clinical practice. American Journal of Preventive Medicine 1993 ; 9 (1). 55-61.
33. Halterman J.S., Fisher S., Conn K.M., et al. Improved preventive care for asthma: a randomized trial of clinician prompting in pediatric offices. Archives of Pediatric & Adolescent Medicine 2006 ; 160 (10). 1018-1025.
34. Harris R.P., OMalley M.S., Fletcher S.W., Knight B.P. Prompting physicians for preventive procedures: a five-year study of manual and computer reminders. American Journal of Preventive Medicine 1990 ; 6 (3). 145-152.
35. Hoch I., Heymann A.D., Kurman I., Valinsky L.J., Chodick G., Shalev V. Countrywide computer alerts to community physicians improve potassium testing in patients receiving diuretics. Journal of the American Medical Informatics Association 2003 ; 10 (6). 541-546.
36. Kenealy T., Arroll B., Petrie K.J. Patients and computers as reminders to screen for diabetes in family practice. Randomized-controlled trial. Journal of General Internal Medicine 2005 ; 20 (10). 916-921.
37. McDonald C.J., Wilson G.A., McCabe G.P., Jr. Physician response to computer reminders. Journal of the American Medical Association 1980 ; 244 (14). 1579-1581.
38. Shea S., DuMouchel W., Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. Journal of the American Medical Informatics Association 1996 ; 3 (6). 399-409.
39. Knight B.P., OMalley M.S., Fletcher S.W. Physician acceptance of a computerized health maintenance prompting program. American Journal of Preventive Medicine 1987 ; 3 (1). 19-24.
40. Schellhase K.G., Koepsell T.D., Norris T.E. Providers reactions to an automated health maintenance reminder system incorporated into the patients electronic medical record. Journal of the American Board of Family Practice 2003 ; 16 (4). 312-317.
41. Krall M.A., Sittig D.F. Subjective assessment of usefulness and appropriate presentation mode of alerts and reminders in the outpatient setting. Proceedings of the AMIA Symposium 2001: 334-338.
42. Payne T.H. Computer decision support systems. Chest 2000 ; 118 (2 Suppl). 47S - 52S.